Breast Cancer Clinical Trial
The REACH Study: A Novel Values-Based Intervention to Increase Endocrine Therapy Adherence Among Breast Cancer Survivors
Summary
This pilot trial compares two online interventions to improve adherence to anti-hormonal medication among women with the most common form of breast cancer (estrogen receptor-positive).
Eligibility Criteria
Inclusion Criteria include:
Women in Colorado treated for Stage 0 to III estrogen receptor-positive breast cancer who have completed primary cancer treatment (surgery, chemotherapy, and/or radiation) and within the past 2.5 years, have been prescribed anti-hormonal therapy
Take their anti-hormonal therapy medication at least occasionally and have at least 1 more year left on their prescription
Report at least 1 factor that makes taking their anti-hormonal therapy medication difficult
Have internet access
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Greenwood Village Colorado, 80111, United States
How clear is this clinincal trial information?